Skip to main content
. 2022 Jan 29;14(3):705. doi: 10.3390/cancers14030705

Figure 3.

Figure 3

Cancer specific survival (CSS) for 49 patients, 43 with locally advanced and 6 patients with local recurrences of rectal adenocarcinomas.